Oppenheimer & Co. Inc. Trims Stock Position in Lam Research Corporation $LRCX

Posted by Andrew Walz on Feb 13th, 2026

Oppenheimer & Co. Inc. cut its holdings in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 15.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 19,155 shares of the semiconductor company’s stock after selling 3,493 shares during the period. Oppenheimer & Co. Inc.’s holdings in Lam Research were worth $2,565,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in LRCX. IMG Wealth Management Inc. purchased a new position in shares of Lam Research during the 2nd quarter worth $26,000. Howard Hughes Medical Institute purchased a new stake in Lam Research in the 2nd quarter valued at about $27,000. Strategic Wealth Investment Group LLC acquired a new position in Lam Research in the second quarter valued at about $29,000. Delos Wealth Advisors LLC purchased a new position in Lam Research during the second quarter worth about $30,000. Finally, Bank of Jackson Hole Trust increased its position in shares of Lam Research by 111.1% during the second quarter. Bank of Jackson Hole Trust now owns 380 shares of the semiconductor company’s stock valued at $37,000 after acquiring an additional 200 shares during the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

Positive Sentiment: Company leadership changes and new partnership efforts aimed at next‑generation chip demand bolster Lam’s positioning in high‑growth segments; this supports medium‑term revenue/growth expectations. Lam Research Reshapes Leadership And Partnerships For Next Generation Chip Demand
Positive Sentiment: Analysts point to secular tailwinds (AI, advanced logic, memory) driving long‑term demand for Lam’s etch and deposition tools, providing a favorable industry backdrop for sustained sales and margin expansion. Analysts cite secular trends for Lam Research Corporation (LRCX)’s development
Positive Sentiment: Sanford C. Bernstein reiterates a constructive view and expects upside, which can support sentiment and buying interest from momentum and institutional investors. Lam Research (NASDAQ:LRCX) Stock Price Expected to Rise, Sanford C. Bernstein Analyst Says
Positive Sentiment: Recent quarterly results showed an EPS and revenue beat with raised guidance (Q3 FY2026 EPS guide 1.25–1.45), underpinning fundamentals and valuation multiple support for the stock.
Neutral Sentiment: Pieces questioning Lam’s long‑run growth runway provide useful context for long‑term investors but contain mixed conclusions — watch thesis details rather than headlines. Does Lam Research Corporation (LRCX) Have a Long Runway for Growth?
Neutral Sentiment: Short‑interest data reported shows no meaningful read (zeros/NaN), so there is no clear short‑pressure signal to explain intraday moves. (Likely a data artifact rather than market action.)
Negative Sentiment: Insider selling headlines (including a 35,000‑share sale by Eric Brandt) are pressuring sentiment and sparking near‑term weakness despite no indication the sales reflect deteriorating fundamentals. Eric Brandt Sells 35,000 Shares of Lam Research (NASDAQ:LRCX) Stock
Negative Sentiment: Related coverage highlights insider selling and notes a short‑term price decline tied to those filings, which can trigger momentum‑driven selling even when fundamentals remain intact. Lam Research (NASDAQ:LRCX) Stock Price Down 1.2% on Insider Selling

Lam Research Price Performance

LRCX stock opened at $231.29 on Friday. The business’s 50-day moving average is $200.23 and its two-hundred day moving average is $154.00. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The firm has a market capitalization of $288.83 billion, a P/E ratio of 47.40, a P/E/G ratio of 2.52 and a beta of 1.78. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $251.87.

Lam Research (NASDAQ:LRCX – Get Free Report) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The firm had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period in the prior year, the firm earned $0.91 earnings per share. The business’s quarterly revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s payout ratio is 21.31%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on LRCX shares. Susquehanna set a $325.00 price objective on shares of Lam Research and gave the stock a “positive” rating in a report on Thursday, January 29th. UBS Group set a $300.00 price target on Lam Research in a research note on Thursday, January 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $320.00 price objective (up from $265.00) on shares of Lam Research in a research note on Thursday, January 29th. HSBC increased their target price on Lam Research from $181.00 to $221.00 and gave the stock a “hold” rating in a research note on Friday, January 30th. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Lam Research in a research report on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $244.88.

View Our Latest Stock Analysis on Lam Research

Insider Buying and Selling

In other Lam Research news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director directly owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.31% of the stock is owned by company insiders.

About Lam Research

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.